Proud to sponsor the Scleroderma Canada conference and thrilled to be participating in Newfoundland. Looking forward to the opportunity to hear from thought leaders, patients, and caregivers in the Scleroderma community!
Mallinckrodt Pharmaceuticals
Pharmaceutical Manufacturing
Listening for Needs, Delivering Solutions
Über uns
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.
- Website
-
http://www.mnk.com
External link for Mallinckrodt Pharmaceuticals
- Industrie
- Pharmaceutical Manufacturing
- Größe des Unternehmens
- 1.001-5.000 Mitarbeiter
- Hauptsitz
- Dublin, Ireland
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1867
- Spezialitäten
- Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis
Standorte
-
Primäre
Wegbeschreibung erhalten
College Business & Technology Park
Dublin, Ireland, IE
-
Wegbeschreibung erhalten
3 Lotus Park
The Causway
Staines-Upon-Thames , Surrey TW18 3AG, GB
-
Wegbeschreibung erhalten
440 Route 22 East
Bridgewater, NJ 08807, US
-
Wegbeschreibung erhalten
675 James S. McDonnell Blvd
Hazelwood, MO 63042, US
Employees at Mallinckrodt Pharmaceuticals
Aktualisierungen
-
Today, we celebrate Women's Equality Day, and the 2024 theme of Inspire Inclusion. It's essential that we work as a global community to accelerate gender parity and continually celebrate the achievements of women. At Mallinckrodt, our annual Women in Business awards recognize outstanding individuals that embody the mission of empowering women to be confident and prepared to reach their full potential in their career aspirations and personal endeavors. It's an opportunity to showcase stories of inspiring women and encourage discussions on how to further support and empower women in the workplace and beyond.
-
-
The AASOG is hosting the 2024 Scientific Conference to help improve care and outcomes in sarcoidosis on August 14th and 15th. We are excited to be attending, stop by and see us! #SarcoidosisAwareness #AASOG
-
-
August is National Wellness Month! Make sure to take time to focus on your mental, emotional, physical, and spiritual well-being. Small daily changes, like taking a short walk, drinking more water, or practicing mindfulness, can lead to big improvements. Prioritize yourself this month and every month! #NationalWellnessMonth #SelfCare #WellnessJourney
-
-
This week is National Minority Donor Awareness Week! Minority donors across the country play a crucial role in saving and enhancing the lives of diverse populations. Registering as an organ donor is quick and easy, and by doing so, you commit to saving lives. Join the movement to foster a positive culture for organ, eye, and tissue donation, and help improve the quality of life in diverse communities. #MinorityDonorAwareness
-
-
Today, we are excited to announce the launch of our new delivery device for appropriate patients with a range of #Inflammatory and #Autoimmune conditions. Learn more about this latest milestone here: https://lnkd.in/ettRnGfF
-
We are thrilled to announce the release of our 2023 Sustainability Report! This report highlights our strategic initiatives, key metrics, and impactful stories behind our sustainability efforts. To delve into the details of our sustainability journey click here https://lnkd.in/g_f2Tfvb #Sustainability #EnvironmentalStewardship #OurCommitment
-
-
The American Association of Kidney Patients is hosting the 6th Annual Global Summit on Kidney Disease Innovations on July 16th and 17th. We are excited to be a sponsor of AAKP’s virtual Global Summit and look forward to learning about new advances in kidney health! #GLOBALKIDNEY2024
-
-
Our team will be onsite at the American Association for Respiratory Care (AARC)’s Summer Forum, showcasing our latest delivery system in the U.S. Attending #AARC Summer Forum? Stop by and see us!
-
-
This year's 13th annual Prevent Blindness Focus on Eye Health Summit will be held on July 10-11, 2024. MNK is a proud sponsor of this virtual summit and looks forward to learning about patient-focused approaches to vision health and eye care. #BeSeenandHeard #FocusOnEyeHealth #VisionHealth #EyeSummit
-